Pretreatment Modified Glasgow Prognostic Score as an Independent Predictor of Clinical Outcome in Patients with Stage I Non-small Lung Cancer after Stereotactic Body Radiation TherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-010OAAI
Prognosis after Local Recurrence or Metastases in Medically Operable Stage I Non-Small Cell Lung Cancer Patients Treated By Stereotactic Body RadiotherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-010OAAI
Stereotactic Body Radiotherapy for Lymph Node Oligometastases.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-010PREAI
Deep Inspiration Breath-Hold Irradiation for Left Side Breast Cancer Using a New Combination of Respiration Monitoring Device and Optical Body Surface Monitoring SystemINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-010OAAI
Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: An Analysis Focusing on MetastasesINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-010OAAI
Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for Totally 380 Patients With Lung MetastasesINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52014-11-018PREAI
Japanese Multi-Institutional Study of Stereotactic Body Radiation Therapy for 380 Patients With Lung MetastasesINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52014-09-011OAAI
Influence of Interstitial Pneumonitis in the Lung on Acute Exacerbation of Interstitial Pneumonia in the Patients Treated With Stereotactic Body Radiation Therapy for Lung CancersINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52013-10-010PREAI
Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factorsBMC CANCERIF3.42013-02-0765OAAI
Rib Fractures After Stereotactic Body Radiation Therapy for Primary Non-small Cell Lung CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52012-11-010PREAI
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapyEUROPEAN JOURNAL OF RADIOLOGYIF3.32012-11-0141PREAI
What is the Cause of Immune Suppression in Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer?INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52012-11-010OAAI
Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patientsRADIATION ONCOLOGYIF3.22011-10-1326OAAI
Stereotactic Body Radiotherapy for Stage I Non-small Cell Lung Cancer Causes Immune SuppressionINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52011-10-010PREAI
Rib Fracture after Stereotactie Body Radiotherapy for 177 Patients with Stage I Non-small Cell Lung CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52010-11-011OAAI